Photo from ESTRO/X
Jul 10, 2024, 06:47
The latest results from the PACE-C trial presented at ESTRO24
ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: .
“Check out the latest results from the PACE-C trial that were presented at ESTRO24, comparing SBRT and MHRT for high-risk prostate cancer with ADT.”
Source: ESTRO/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 22, 2024, 12:06
Oct 22, 2024, 11:04
Oct 22, 2024, 10:18
Oct 22, 2024, 10:12
Oct 22, 2024, 09:38
Oct 22, 2024, 08:02
Oct 22, 2024, 07:20